11:03 , Jun 22, 2017 |  BC Innovations  |  Emerging Company Profile

Repare in progress

With a $68 million series A co-led by Versant Ventures and MPM Capital, Repare Therapeutics Inc. emerged from 18 months of stealth today, making a splash in the growing pool of newcos targeting cancer via...
20:50 , Mar 31, 2017 |  BioCentury  |  Finance

It takes two

Third Rock set up Tango Therapeutics Inc. and provided it with a $55 million A round to use advanced technologies to industrialize the discovery of targets and compounds that can induce synthetic lethality. While several...
07:00 , Apr 11, 2016 |  BC Week In Review  |  Financial News

Metabomed financial update

Metabomed Ltd. , Yavne, Israel   Business: Cancer   Date announced: 2016-04-04   Note: Metabomed raised an undisclosed amount in an extension of a series A round, bringing the total raised to $18 million. New...
00:33 , Apr 5, 2016 |  BC Extra  |  Financial News

Metabomed caps $18M series A

Cancer play Metabomed Ltd. (Yavne, Israel) said it raised an undisclosed amount in an extension of its series A round, bringing the round's total to $18 million. New investors Pfizer Inc. (NYSE:PFE) and Arkin Holdings...
08:00 , Dec 9, 2013 |  BC Week In Review  |  Financial News

Metabomed completes venture financing

Metabomed Ltd. , Yavne, Israel   Business: Cancer   Date completed: 11/26/13   Type: Venture financing   Raised: Not disclosed   Investors: MS Ventures; Boehringer Ingelheim Venture Fund; Pontifax; Technion Research and Development Foundation  ...
01:10 , Nov 27, 2013 |  BC Extra  |  Financial News

Merck Serono's Israeli incubator debuts two newcos

The Merck Serono Israel Bioincubator debuted two newcos on Tuesday with undisclosed seed financings led by MS Ventures, the strategic corporate fund of the Merck Serono division of Merck KGaA (Xetra:MRK). Metabomed Ltd. (Yavne, Israel)...